Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: aspirin / ciprofloxacin / procardia / niacin / biaxin / niaspan / ibuprofen / crestor / quinolones / neosporin / adhesive tape attending: chief complaint: dyspnea major surgical or invasive procedure: bronchoscopy picc placement history of present illness: this is a 64f with sarcoidosis, h/o left lower lobe wedge resection for pulmonary nodules, and tracheobronchomalacia who was recently admitted () for removal of y stent and debridement of granulation tissue in the l mainstem bronchus who now presents with increased shortness of breath--could not walk to bathroom without severe dyspnea--went to osh, found to be in rapid afib; started dilt gtt at osh, and transferred here, where she was in sinus rhythm on dilt gtt. however, still dyspneic. in the ed, still on dilt gtt. cta looks like collapse of lll (no pe); ip aware, and plan bronch tomorrow (npo p mn, coags buffed). 85, 102/65, 25, 93-6% 3l. ros: had been constipated during recent hospital stay, then had large bm at home. the patient denies any fevers, chills, weight change, nausea, vomiting, abdominal pain, melena, hematochezia, chest pain, orthopnea, pnd, lower extremity oedema, urinary frequency, urgency, dysuria, lightheadedness, gait unsteadiness, focal weakness, vision changes, headache, rash or skin changes. past medical history: 1. obesity. 2. history of pericarditis/tamponade secondary to polyserositis. she has been on steroids for this for the past 17 years. 3. history of pleural effusion. 4. sarcoidosis. 5. gerd. 6. history of lung nodule status post thoracotomy with left lower lobe wedge resection ( ). 7. asthma. 8. hiatal hernia. 9. osa on nocturnal cpap (plus 12) 10. hypertension. 11. lactose intolerance. 12. tracheobronchomalacia; had y stent placed , with no improvement in dyspnea but worse , it was removed . social history: the patient is divorced. she lives alone in , . she has one son who lives close by. she has been on disability since . prior to that, she worked as a financial analyst. she has a rare glass of wine. she quit smoking in . prior to that she smoked a pack a day for 40 years. she has never used any illicit drugs. she denies asbestos exposure and reports no known tuberculosis exposures. she had a negative ppd test last year prior to starting enbrel therapy. family history: there is no family history of lung disease or sarcoid. her mother died secondary to rectal cancer 82 years old. notably she did have lupus. her father died secondary to an mi at 72 years old. her son is healthy. physical exam: vitals: t:98.5 bp:154/39 hr:75 rr:12 o2sat:97% 3l gen: well-appearing, well-nourished, no acute distress heent: eomi, perrl, sclera anicteric, no epistaxis or rhinorrhea, mmm, op clear neck: no jvd, carotid pulses brisk, no bruits, no cervical lymphadenopathy, trachea midline cor: rrr, no m/g/r, normal s1 s2, radial pulses +2 pulm: lungs ctab, no w/r/r abd: soft, nt, nd, +bs, no hsm, no masses ext: no c/c/e, no palpable cords neuro: alert, oriented to person, place, and time. cn ii ?????? xii grossly intact. moves all 4 extremities. strength 5/5 in upper and lower extremities. patellar dtr +1. plantar reflex downgoing. no gait disturbance. no cerebellar dysfunction. skin: no jaundice, cyanosis, or gross dermatitis. no ecchymoses pertinent results: 03:53pm glucose-135* na+-139 k+-4.5 cl--94* tco2-31* 03:45pm urea n-13 creat-0.5 03:45pm ck(cpk)-24* 03:45pm ctropnt-<0.01 03:45pm ck-mb-notdone 03:45pm wbc-18.8* rbc-4.52 hgb-12.0 hct-35.5* mcv-79* mch-26.5* mchc-33.7 rdw-14.9 03:45pm neuts-91.0* lymphs-5.6* monos-1.9* eos-1.1 basos-0.3 03:45pm plt count-778* 03:45pm pt-14.1* ptt-28.5 inr(pt)-1.2* 04:15pm urine blood-lg nitrite-neg protein-neg glucose-neg ketone-neg bilirubin-neg urobilngn-neg ph-7.0 leuk-neg laboratories: osh labs this morning notable for tni 0.04, bnp 17, cbc and lytes similar to ed labs here. ecg: sinus rhythm at 91 bpm, nml axis, incomplete rbbb, ant t waves are flat, similar to . imaging: cxr: there is atelectasis at the left lung base. there is stable cardiomegaly. the right lung is clear. conclusion: minimal stable atelectasis in the left lower lobe with no acute cardiopulmonary process. cta chest : impression: 1. no pulmonary embolism. 2. worsening left basilar collapse, presumably secondary to collapse of the left mainstem bronchus, likely due to the patient's known diagnosis of tracheobronchomalacia. extrinsic compression is less likely, though there is some increased soft tissue surrounding the area of the collapsed left mainstem bronchus, and scattered borderline mediastinal lymph nodes as previously described. tte : the left atrium is mildly dilated. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity size is normal. overall left ventricular systolic function is normal (lvef 70%). there is no ventricular septal defect. right ventricular chamber size and free wall motion are normal. the aortic arch is mildly dilated. there are focal calcifications in the aortic arch. the aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. the mitral valve appears structurally normal with trivial mitral regurgitation. there is no mitral valve prolapse. there is mild pulmonary artery systolic hypertension. there is no pericardial effusion. brief hospital course: 64yof with tracheobronchomalacia, recently admitted for removal of y stent in the l mainstem, now with lll collapse, likely from mucus plugging, pt was admitted to the for new onset afib requiring a diltiazem drip. . # dyspnea/lll collapse: bronchoscopy revealed reaccumulation of granulation tissue and mucous which appeared purulent. bal could not be sent due to limited size of her airways. she was started on vanc/cefepime day 1=, 7 day course complete on for healthcare associated pneumonia. picc line was placed . pt was continued on suppressants, supplemental oxygen as needed, and nebulizer treatments. sats remained stable throughout this hospitalization on 2-3l oxygen via nasal cannula. . # afib: pt has had new afib observed over a few days prior to her unit admission, with poor rate control on arrival from osh. pt was initially transferred from the ed to the icu on a diltizaem however several hours into admission was able to be weaned to po diltiazem and metorpolol. given her chads2 score of 1, pt was not started on anticoagulation. noted to be in sinus rhythm on day of transfer so no dccv was initiated. a tsh was checked for the a. fib work up and was 0.081 with a free t4 of 1.9. she had no further episodes of atrila fibrillation hd . tte on revealed mildly dilated left atrium. lvef 70%. # htn: on micardis 40/12.5 at home, as well as lasix and toprol xl 25mg daily. her toprol was continued at her home dose, but her outpatient micardis was held. she was started on diltiazem 30mg qid for control of her atrial fibrillation as well as control of her blood pressure. her blood pressure was stable on this regimen. # asthma: pt was continued on montelukast, advair 250-50 . # allergic rhinitis: pt was continued on fluticasone nasal, zyrtec . # sarcoidosis, h/o serositis: not active. continued prednisone taper and bactrim for pjp prophylaxis. . # chronic pain: continued cyclobenzaprine, oxycodone . # osa: continued home cpap of 12 cm h20 in the out patient: diltiazem can be changed to long acting formulation, or alternatively, discontinued, and her bbloker dose can be increased to 50 mg daily to minimize her medications. medications on admission: 1. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 2. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 3. benzonatate 100 mg capsule sig: one (1) capsule po tid (3 times a day). 4. multivitamin tablet sig: one (1) tablet po daily (daily). 5. calcium carbonate 500 mg tablet, chewable sig: two (2) tablet, chewable po bid (2 times a day). 6. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po daily (daily). 7. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 8. cyclobenzaprine 10 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 9. fluticasone 50 mcg/actuation spray, suspension sig: two (2) spray nasal daily (daily). 10. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed. 11. oxycodone 5 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed. disp:*50 tablet(s)* refills:*0* 12. prednisone 10 mg tablet sig: four (4) tablet po once a day for 2 days. disp:*25 tablet(s)* refills:*0* 13. prednisone 10 mg tablet sig: three (3) tablet po daily (daily) for 3 days. 14. prednisone 10 mg tablet sig: two (2) tablet po daily (daily) for 3 days: then 1 x days, then tablet (5mg) x 3 days. 15. saline solution sig: three (3) ml miscellaneous three times a day: nebulizers.disp:*300 * refills:*2* 16. micardis hct 40-12.5 mg tablet sig: one (1) tablet po once a day. 17. nexium 40 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po three times a day. 18. zyrtec 10 mg tablet sig: one (1) tablet po once a day. 19. cyproheptadine 4 mg tablet sig: one (1) tablet po twice a day. 20. lasix 20 mg tablet sig: one (1) tablet po once a day as needed. 21. toprol xl 25 mg tablet sustained release 24 hr sig: 0.5 tablet sustained release 24 hr po once a day.disp:*15 tablet sustained release 24 hr(s)* refills:*2* discharge medications: 1. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed. 2. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. 3. benzonatate 100 mg capsule sig: one (1) capsule po tid (3 times a day). 4. diltiazem hcl 30 mg tablet sig: one (1) tablet po qid (4 times a day). 5. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 6. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 7. prednisone 10 mg tablet sig: three (3) tablet po daily () for 1 days: . 8. prednisone 20 mg tablet sig: one (1) tablet po daily () for 3 days: . 9. prednisone 10 mg tablet sig: one (1) tablet po daily () for 3 days: . 10. prednisone 5 mg tablet sig: one (1) tablet po daily () for 3 days: . 11. fluticasone 50 mcg/actuation spray, suspension sig: one (1) spray nasal daily (daily). 12. cyclobenzaprine 10 mg tablet sig: one (1) tablet po tid (3 times a day) as needed. 13. calcium carbonate 500 mg (1,250 mg) tablet sig: one (1) tablet po every twelve (12) hours. 14. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po daily (daily). 15. heparin (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 16. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 17. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 18. multivitamin tablet sig: one (1) tablet po daily (daily). 19. cyproheptadine 4 mg tablet sig: one (1) tablet po bid (2 times a day). 20. oxycodone 5 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed. 21. trimethoprim-sulfamethoxazole 160-800 mg tablet sig: one (1) tablet po bid (2 times a day). 22. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). 23. chlorpheniramine-hydrocodone 8-10 mg/5 ml suspension, sust.release 12 hr sig: five (5) ml po q12h (every 12 hours) as needed. 24. metoprolol succinate 25 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po daily (daily). 25. menthol-cetylpyridinium 3 mg lozenge sig: one (1) lozenge mucous membrane prn (as needed). 26. codeine-guaifenesin 10-100 mg/5 ml syrup sig: 5-10 mls po q6h (every 6 hours). 27. insulin regular human 100 unit/ml solution sig: one (1) injection asdir (as directed): see attached insulin sliding scale. 28. ondansetron 4 mg iv q8h:prn 29. cefepime 2 g iv q12h 30. vancomycin 1000 mg iv q 12h 31. furosemide 20 mg tablet sig: one (1) tablet po once a day as needed for fluid overload. 32. saline mist 0.65 % aerosol, spray sig: one (1) nasal four times a day as needed. discharge disposition: extended care facility: discharge diagnosis: primary: left lower lobe collapse tracheobronchomalacia atrial fibrillation secondary: sarcoidosis obstructive sleep apnea hypertension obesity discharge condition: stable discharge instructions: you were admitted for collapse of your left lower lobe due to your tracheobronchomalacia. while you were here, you had bronchoscopy which revealed granulation tissue and mucous plugging. you were started on antibiotics to treat a hospital acquired pneumonia, you should continue these until a 7 day course is complete on . while you were here, you had atrial fibrillation. you were started on a new medication called diltiazem to control your heart rate. this also helps to control your blood pressure. you should continue to take this medication outpatient. also, because it helps to control your blood pressure, your other blood pressure medication, micardis, was held. if necessary, this can be restarted outpatient. if you should have worsening shortness of breath, fever/chills, headache/dizzyness, you should call your regular doctor or present to the emergency department. it is very important that you take all of your medications as directed and follow up with your appointments. followup instructions: you have the following appointments: antibiotic regimen complete (day 1 of ctx/vanc= ) provider: clinic interventional pulmonary (sb) phone: date/time: 10:30 provider: , md phone: date/time: 10:00 procedure: venous catheterization, not elsewhere classified fiber-optic bronchoscopy other intubation of respiratory tract diagnoses: pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) other chronic pain esophageal reflux unspecified essential hypertension long-term (current) use of steroids atrial fibrillation sarcoidosis pulmonary collapse diaphragmatic hernia without mention of obstruction or gangrene obesity, unspecified constrictive pericarditis intestinal disaccharidase deficiencies and disaccharide malabsorption lung involvement in other diseases classified elsewhere other diseases of trachea and bronchus extrinsic asthma, unspecified 

Answer: The patient is high likely exposed to